FedBizOpps banner

Login to begin searching the FBO/CBD
Home Page
CBD/FBO Online
CBD/FBO Email
About Us
Contact Us
Privacy
Categories
No. Notes
Archives
Search
Help
Login
Register

Popular Searches

Popular Categories

Sunscreen Clinical Study - Attachment A - FDA-18-RFQ-1192863

General Information

Document Type:PRESOL
Posted Date:Feb 16, 2018
Category: Special Studies and Analyses - Not R&D
Set Aside:N/A

Contracting Office Address

Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States

Description

Request for Quote: Sunscreen Clinical Study Detailed Study Description The U.S. Food and Drug Administrations (FDA) Center for Drug Evaluation and Research (CDER), Division of Applied Regulatory Science has a requirement for contractor services to conduct a two-part clinical study on sunscreen This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a separate written solicitation will not be issued. This solicitation is a Request for Quote (RFQ) using FAR Parts 12 and 13.5 procedures. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-95. The North American Industry Classification System (NAICS) code for the proposed acquisition is 541690, Other Scientific and Technical Consulting Services. For full description/details, please refer to attached document "FDA-18-RFQ-1192863.pdf"

Original Point of Contact

POC Christopher R. McGucken, Phone: (240) 402-7599

Place of Performance

Link: FBO.gov Permalink
Bookmark This Notice
Print View